3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
cyclopia sequence
7
Neoplasms
6
Multiple Myeloma
6
Fatigue
6
Neoplasms, Plasma Cell
5
Neoplasm Metastasis
4
Lung Neoplasms
4
Dyspnea
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Uterine Cervical Neoplasms
3
Tobacco Use Cessation
3
Prostatic Neoplasms
3
Primary Myelofibrosis
3
Leukemia
3
Head and Neck Neoplasms
3
Depression
3
Carcinoma, Renal Cell
3
Vomiting
2
Smoking Cessation
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Parasomnias
2
Pancreatic Neoplasms
2
Pain
2
Osteosarcoma
2
Kidney Neoplasms
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Interventions
Pemetrexed
12
Cisplatin
11
pembrolizumab
8
Carboplatin
6
Ipilimumab
5
Nivolumab
4
LMB-100
4
durvalumab
3
Gemcitabine
3
tremelimumab
2
tazemetostat
2
anetumab ravtansine
2
Vinorelbine
2
Plicamycin
2
Dexamethasone
2
Cyclophosphamide
2
Bevacizumab
2
vandetanib
1
tocilizumab
1
spartalizumab
1
ribociclib
1
rebastinib
1
pevonedistat
1
olaparib
1
niraparib
1
nintedanib
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma
×
Surveys and Questionnaires
×
Clear all
No trials found.